Literature DB >> 31631057

Cerebellar transcranial magnetic stimulation: The role of coil type from distinct manufacturers.

Danny Spampinato1, Jaime Ibáñez2, Manos Spanoudakis3, Paul Hammond3, John C Rothwell3.   

Abstract

BACKGROUND: Stimulating the cerebellum with transcranial magnetic stimulation is often perceived as uncomfortable. No study has systematically tested which coil design can effectively trigger a cerebellar response with the least discomfort.
OBJECTIVE: To determine the relationship between perceived discomfort and effectiveness of cerebellar stimulation using different coils: MagStim (70 mm, 110 mm-coated, 110-uncoated), MagVenture and Deymed.
METHODS: Using the cerebellar-brain inhibition (CBI) protocol, we conducted a CBI recruitment curve with respect to each participant's maximum tolerated-stimulus intensity (MTI) to assess how effective each coil was at activating the cerebellum.
RESULTS: Only the Deymed double-cone coil elicited CBI at low intensities (-20% MTI). At the MTI, the MagStim (110 mm coated/uncoated) and Deymed coils produced reliable CBI, whereas no CBI was found with the MagVenture coil.
CONCLUSION: s: The Deymed double-cone coil was most effective at cerebellar stimulation at tolerable intensities. These results can guide coil selection and stimulation parameters when designing cerebellar TMS studies. Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebellar-M1; Cerebellum; Connectivity; Transcranial magnetic stimulation

Mesh:

Year:  2019        PMID: 31631057     DOI: 10.1016/j.brs.2019.09.005

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  9 in total

1.  Cerebellar-Motor Cortex Connectivity: One or Two Different Networks?

Authors:  Danny A Spampinato; Pablo A Celnik; John C Rothwell
Journal:  J Neurosci       Date:  2020-04-20       Impact factor: 6.167

Review 2.  The Effect of Cerebellar rTMS on Modulating Motor Dysfunction in Neurological Disorders: a Systematic Review.

Authors:  Yifei Xia; Mingqi Wang; Yulian Zhu
Journal:  Cerebellum       Date:  2022-08-26       Impact factor: 3.648

3.  Cerebellar transcranial direct current stimulation disrupts neuroplasticity of intracortical motor circuits.

Authors:  Wei-Yeh Liao; Ryoki Sasaki; John G Semmler; George M Opie
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

4.  Reduced Cerebellar Brain Inhibition Measured Using Dual-Site TMS in Older Than in Younger Adults.

Authors:  B K Rurak; J P Rodrigues; B D Power; P D Drummond; A M Vallence
Journal:  Cerebellum       Date:  2021-04-20       Impact factor: 3.847

Review 5.  Interactions Between Cerebellum and the Intracortical Excitatory Circuits of Motor Cortex: a Mini-Review.

Authors:  George M Opie; Wei-Yeh Liao; John G Semmler
Journal:  Cerebellum       Date:  2021-05-12       Impact factor: 3.847

6.  Frequency-dependent modulation of cerebellar excitability during the application of non-invasive alternating current stimulation.

Authors:  Danny Spampinato; Esin Avci; John Rothwell; Lorenzo Rocchi
Journal:  Brain Stimul       Date:  2021-01-20       Impact factor: 8.955

7.  Effects of the Intermittent Theta Burst Stimulation of the Cerebellar Vermis on Balance Recovery After Stroke: A Study Protocol for a Randomized Controlled Trial.

Authors:  Lin Wang; Guilan Huang; Li Zhang; Jinyu Yang; Caili Ren; Chengpan Liang; Ying Shen; Bin Su
Journal:  Front Aging Neurosci       Date:  2022-04-29       Impact factor: 5.750

8.  Repetitive transcranial magnetic stimulation (rTMS) as a therapeutic option in paraneoplastic cerebellar ataxia - a case report.

Authors:  Nicoleta Jemna; Ana Calina Zdrenghea; Georgiana Frunza; Anca Demea; Dafin Fior Muresanu
Journal:  J Med Life       Date:  2022-06

9.  Efficacy of Intensive Cerebellar Intermittent Theta Burst Stimulation (iCiTBS) in Treatment-Resistant Schizophrenia: a Randomized Placebo-Controlled Study.

Authors:  Preeti Chauhan; Shobit Garg; Sai Krishna Tikka; Sumit Khattri
Journal:  Cerebellum       Date:  2020-09-22       Impact factor: 3.847

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.